作者: Michael J. Thun , Eric J. Jacobs , Carlo Patrono
DOI: 10.1038/NRCLINONC.2011.199
关键词: Health outcomes 、 Surgery 、 Aspirin 、 Colorectal cancer 、 Cancer prevention 、 Medicine 、 Incidence (epidemiology) 、 Cancer incidence 、 Internal medicine 、 Platelet activation 、 Cancer
摘要: … was observed in long-term follow up of the Thrombosis Prevention Trial (TPT), 30 which used a controlled-release formulation of 75 mg aspirin with negligible systemic bioavailability. …